젊은 연구자 시상 및 수상자 특강 안내
[2012-04-27]
춘계 당뇨병 연구비 시상 안내
[2012-04-27]
포스터 구연 안내
[2012-04-04]
포스터 전시 안내
[2012-04-04]
Newsletter. 1
[2012-02-28]
Newsletter. 2
[2012-03-05]
Newsletter. 3
[2012-04-06]
Newsletter. 4
[2012-05-07]
PL 1. From metabolic syndrome to diabetes
손호영 (가톨릭의대 내과)
PL 2. Meta-inflammation responsible for the progression from obesity to metabolic syndrome originates in the endoplasmic reticulum stressed tissues
정헌택 (울산대 생명과학부)
S1 Clinical diabetes & therapeutics 1
S1-1 The mechanism of hypoglycemia unawareness
S1-2 Hypoglycemia as a risk factor for cardiovascular disease and mortality
S1-4 Effects of hypoglycemia on brain
S1-5 How to reduce hypoglycemia in treating patients with diabetes
S2 Epidemiology & genetics
S2-1 Identification of genetic basis for type 2 diabetes in East Asian populations
S2-2 GWA study for gestational diabetes in Koreans
S2-3 Genetic susceptibility to retinopathy in type 2 diabetes
S2-4 Genetic association study for cardiovascular disease in Yonsei Cardiovascular Center
S3 Islet biology & insulin secretion
S3-1 Role of mitochondrial ROS induced by high calorie diet in pancreatic β-cell destruction
S3-2 SPA0355 prevents cytokine-mediated β-cell death and
streptozotocin-induced diabetes
S3-3 Endothelial progenitor cell co-transplantation enhances islet engraftment by rapid
revascularization
S3-4 Generation of pancreatic β-cells from enteroendocrine K-cells
S4 Education
S4-1 Medical humanities in metabolic syndrome
S4-2 Effect of weight loss on metabolic and cardiovascular outcomes
S4-3 The impact of exercise in the development and treatment of metabolic syndrome
S4-4 Surgical treatment of obesity
S5 Diabetic complications 1
S5-1 Cardiovascular risk management in asymptomatic diabetic patient
S5-2 Screening and management of asymptomatic cardiovascular disease in
diabetic patients
S5-3 Clinical characteristics and impact of peripheral vascular disease in diabetes
S5-4 Treatment and outcomes of peripheral vascular disease in Korean diabetic patients
S6 Insulin resistance
S6-1 Basics of microRNA study in diabetes
S6-2 MicroRNA regulation of lipid homeostasis
S6-3 Phytochemicals alter diet induced obesity by regulating miRNAs expression
S6-4 The role of microRNAs in mitochondrial dysfunction-induced insulin resistance
S7 Obesity
S7-1 Cardiac dysfunction and lipid metabolism in the heart
S7-2 X-box binding protein 1 is a novel regulator for peroxisome
proliferator-activated receptor γ2 expression and activation in 3T3-L1 cells
S7-3 PPARγ phosphorylation and anti-diabetic action
S7-4 Immune responses in adipose tissue of obesity
S8 Self care
S8-1 Diabetic education with patient empowered-self managements
S8-2 The goal of evidence-based A1c(glucose control) and management
S8-3 The goal of evidence-basal blood pressure control and management
S8-4 The goal of evidence-based cholesterol control and management
S8-5 The goal of evidence-based weight control and management
S9 Clinical diabetes & therapeutics 2
S9-1 Perspectives of endocrinology
S9-2 Perspectives of surgery
S9-3 Insulin secretory defect is predominant
S9-4 Is insulin resistance the primary defect of type 2 diabetes in Korean?
S10 Clinical diabetes & therapeutics 3
S10-1 Pharmacological management of pre-diabetes
S10-2 Blood glucose control in critically ill patients
S10-3 Control of residual CV risk management in type 2 diabetes mellitus
S10-4 Current status of gene therapy for diabetes mellitus
S11 Diabetic complications 2
S11-1 Endoplasmic reticulum stress and atherosclerosis
S11-2 Essential role of vitamin D receptor and Runx2 as lineage reprogramming factors
during transdifferentiation of smooth muscle cells into osteoblast-like cells by high
dose vitamin D
S11-3 NOD2: a novel modulator of vascular disease
S11-4 Platelet hyper-responsivenss in diabetes
S12 Nutrition
S12-1 Sodium threshold and the efficacy of reduction of sodium intake- salt
sensitive hypertension
S12-2 Epidemiologic evidence of sodium intake with CV risk and
sodium J curve as new explanation
S12-3 Salt in hypertension: dietary approach to stop hypertension
S12-4 Salt in diabetes: is there a problem?
Joint symposium
1. Network biology approaches to find mitochondrial disease genes
and diabetes comorbidity
2. Hypotensive effect by activation of NAD(P)H: quinone
oxidoreductase 1 via modualation of eNOS activity
3. Cell-based screening of novel diabetic therapeutics using cells
with H2AX knock-down-mediated mitochondrial deficits
4. Mitochondria function and vascualr calcification
5. The cotranslational regulation of OXPHOS polypeptides in mammalian
mitochondria and its potential implications in degenerative diseases including
insulin resistance
6. Exchange protein directly activated by cAMP 1 is involved in
induction of brown adipose tissue in white adipose tissue
In-depth symposium
1. Emerging clinical applications of leptin
2. The regulation of insulin secretion through adipokines
3. Improvement of leptin resistance
4. Proteomic approach for mining biomarkers in diabetes and obesity
Meet the experts
1. Metabolic syndrome in adolescents
2. Insulin treatment
3. Psycosocial understanding of children and adolescents with diabetes and
education for diabetes
4. Daegu-Kyungpook diabetes camp (1992-2011)
5. Type 1 diabetes registry
POCT (point of care testing), a step to future
1. The importance of POCT in diabetes management
2. Recommendations for POCT quality control focusing on HbA1c
3. Prospects for medical insurance coverage of HbA1c, ketone test using POCT in Korea
Basic and clinical approach of gestational DM
1. Adaptation of β-cell to pregnancy
2. Diagnosis, screening, & antepartum risk factors for GDM
3. Nutritional risk factors for T2DM in women with GDM
4. Long-term outcome in offspring of mothers with GDM
Diabetes in elderly Korean
1. Diabetes and geriatric syndrome
2. The status of diabetes management in elderly Koreans
3. Prevalence and risk factor of chronic kidney disease in elderly diabetic patients in Korea
제25차 대한당뇨병학회 춘계학술대회_1st Announcement.pdf
제25차 대한당뇨병학회 춘계학술대회_2nd Announcement.pdf
제25차 대한당뇨병학회 춘계학술대회_Final Announcement.pdf